Gene: ACTMAP
Official Full Name: actin maturation proteaseprovided by HGNC
Gene Summary: Enables cysteine-type aminopeptidase activity and initiator methionyl aminopeptidase activity. Involved in protein processing. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20019 | ACTMAP Knockout cell line (HeLa) | Human | ACTMAP | 1:3~1:6 | Negative | Online Inquiry |
KO20020 | ACTMAP Knockout cell line (HCT 116) | Human | ACTMAP | 1:2~1:4 | Negative | Online Inquiry |
KO20021 | ACTMAP Knockout cell line (HEK293) | Human | ACTMAP | 1:3~1:6 | Negative | Online Inquiry |
KO20022 | ACTMAP Knockout cell line (A549) | Human | ACTMAP | 1:3~1:4 | Negative | Online Inquiry |
ACTMAP Gene Knockout Cell Lines are engineered cellular models designed to facilitate the study of gene function and contribute to gene-targeted therapeutic strategies. These cell lines are meticulously developed using CRISPR-Cas9 gene editing technology, which allows for precise deletion of specific genes, thereby enabling researchers to observe phenotypic changes resulting from the absence of those genes. This advanced method of genetic alteration not only enhances the specificity of the knockout but also minimizes potential off-target effects that are often encountered with conventional methods.
The core function of ACTMAP Gene Knockout Cell Lines lies in their ability to serve as valuable tools for elucidating the roles of genes in various biological processes. By systematically knocking out genes of interest, researchers can investigate cellular pathways, validate drug targets, and explore disease mechanisms. In clinical settings, these cell lines may also play a pivotal role in the development of personalized medicine, allowing for tailored therapeutic approaches based on the genetic makeup of individual patients.
One of the key advantages of ACTMAP Gene Knockout Cell Lines is their broad applicability across multiple research domains, including cancer biology, neurobiology, and drug development. Unlike traditional cell lines, our products come with pre-validated knockout efficiencies, ensuring reliability and reproducibility of experimental results. Furthermore, ACTMAP provides comprehensive support and documentation, assisting researchers in utilizing these cell lines effectively.
For researchers and clinicians seeking to advance their understanding of gene function and to innovate therapeutic interventions, ACTMAP Gene Knockout Cell Lines represent a cutting-edge solution that enhances investigative outcomes. With years of expertise in genetic engineering and a commitment to quality, our company stands at the forefront of biological product development, continually delivering tools that empower scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.